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Summary
1. By a procedure involving adsorption to barium sulfate, chromatogtaphy
on DEAE-Sephadex and QAE-Sephadex and preparative polyacrylamide gel
electrophoresis, deca.rboxyfactor X was purified from plasma of phenpro-
coumon-treated cows. No contaminants could be detected in the final prepara-
tion by polyacryIamide gel electrophoresis and zone-electrophoresis.
2. The molecular weight of decarboxyfactor X, as determined by sodium
dodecyl sulfate polyacrylamide gel electrophoresis is approximately 55 000,
which is equal to that of factor X. The protein consists of two polypeptide
chains with molecular weights of 44 000 and 17 000.
3. Decarboxyfactor X has antigenic determinants in common with normal
factor X.
4. The amino acid composition and aminoterminal amino acids of normal
factor X and decarboxyfactor X are identical.
5. Less than one residue of 7-carboxyglutamate could be detected per mole
of decarboxyfactor X.
6. In the absence of Ca2*, normal factor X has a slightly higher electro-
phoretic mobility than decarboxyfactor X. In the presence of Ca2* the mobility
of factor X decreases considerably while the mobility of decarboxyfactor,X
remains unaltered.
Introduction
In several laboratories a decarboxyprothrombin present in plasma of
dicoumarol-treated cattle has been extensively purified and characterized
J U J
[1 -4]. The structural comparison of normal and dicoumarol-induced pro-
thrombin has been the subject of intensive investigations in recent years [5--9].
It is now clear that prothrombin contains a number of 7-carboxyglutamate
residues in the aminoterminal region, whereas glutamate residues are found in
the aminoterminal region of decarboxyprothrombin.
These results and experiments on the biosynthesis of prothrombin [10 -12]
confirm the earlier suggestion of Hemker et al. [13] that decarboxyprothrom-
bin is a precursor of normal prothrombin, which accumulates because of a
decreased turnover of the vitamin K-dependent conversion of decarboxypro-
thrombin into prothrombin.
Since there are four vitamin-K dependent coagulation factors, one can postu-
Iate the existence of four decarboxy blood coagulation factors. We reported
earlier the demonstration of both decarboxyfactor IX and decarboxyfactor X
[14,15]. In this paper we describe the purification and partial characterization
of decarboxyfactor X. The purification of decarboxyfactor X is of particular
interest because it may be a suitable tool in studying the role of ca2* in the
activation of factor X and their role in prothrombinase. especiallv on the
proteolytic activity of factor X,.
Materials
Normal bovine factors II, IX, and X used for the immunization of rabbits
were purified according to the method of Reekers [16]. Common inorganic
chemicals (reagent grade), barium sulfate, acrylamide, l/ 'f l '-methylene bis-
acrylamide and benzamidine hydrochloride were obtained from Merck, Darm-
stadt, G.F.R. Several other types of Basoa tested gave the same results with
minor quantitative differences. Marcoumar was a kind gift of Dr. M. Kunz
(Hoffmann-La Roche, Basle, Switzerland). DEAE-Sephadex and eAE-
sephadex (Pharmacia, Uppsala, sweden) were equilibrated according to the
instructions supplied by the manufacturers. Agarose was a product of Koch-
Light Laboratories Ltd. Aluminum hydroxide moist gel was purchased from
British Drug Houses Ltd. Sodium dodecyl sulfate (Koch-Light Laboratories
Ltd.) was recrystallized from ethanol. Bovine serum albumin, glutamate
dehydrogenase, ovalbumin, carbonic anhydrase, lysozyme, myoglobin,
a-chymotrypsin-A, soybean trypsin inhibitor, diisopropylfluorophosphate and
dansylchloride were obtained from Sigma Chemical Co.
Reference dansylamino acids were supplied by calbiochem A.G. polyamide
layer sheets were obtained from Merck. Vitamin K and heparin were purchased
from Hoffmann-La Roche.
Methods
Preparation of rabbit anttbouine factor II and IX antiserum
Antisera were prepared in rabbits by injection of purified preparations of
bovine factor II and factor IX [15]. Antisera were adsorbed with barium sul-
fate (100 mg/ml) for 30 min at room temperature and heat inactivation was
performed for 30 min at 56'c in order to remove procoagulant activity. The
adsorbed and inactivated antisera were centrifuged for t h at 105 000 X g at
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4'C. Sodium merthiolaLe (O.OI% final concentration) was added before 
storage
aL -20" C.
Preparation of rabbit antibouine factor X antiserum
For the immunization of rabbits, we used a factor X2 preparation 
purified as
described under Methods. The first intramuscular injection was 
given at four
different places with 1.0 ml factor x2 Q.2 rng/ml)mixed with 1.0 ml 
complete
Freund's adjuvant. A second and third intramuscular injection of 1'0 
ml factor
X, (0.2 mgiml) mixed with 1'0 ml incomplete Freund's adjuvant was 
given
after intervals of 3 weeks. Plasmaphoresis was performed after the 
second
month. Antisera were treated as described above'
Gel electroPhoresis
Analytical poiyacrylamide gel electrophoresis was performed according 
to
ornstein [17],  using utr i r .HCl 
.glyclnate buffer system as described by Davis
[18]. polyaciytamiie gel,electrophoresis in sodium 
dodecyl sulfate (SDS) rvas
carried out accordir",i to Webei and Osborn [19]' Bovine serum 
albumin'
glutamate dehydrogeriase, ovalbumin, carbonic anhydrase, a-chymotrypsinogen
A , m y o g l o b i n a n d l y s o z y m e w e r e u s e d a s m a r k e r s f o r t h e m o l e c u l a r w e i g h t
estimation, urir-,g -ole"uiar weights given by weber and osborn [19]. 
The gels
were stained according to Faiibanks [20]. Equipment for analytical 
poly-
acrylamide gel electropioresis was obtained from Buchler Instruments 
(Poly-
analy st) .
Agarose gel electrophoresis was carried out in 1.5 mm lhickT% 
agarose gelg
i n 0 . 0 5 M b a r b i t a l b u f f e r p H s ' 6 c o n t a i n i n g 2 . O m M c a l c i u m l a c t a t e o r 2 . 0 m M
EDTA by the method of iohansson [21]. Elec^trophoresis 
was run at 15 V per
cm on a glass plate and cooled by water of 10'C' The 
gels were fixed in 10%
trichloroacetic acid and stained with coomassie Brill iant 
Blue G (Sigma chemi-
cal Co.) in 7O% acetic acid' A LKB Multiphor 27!7 apparatus 
was used'
Immuno ch emical me tho ds
'Decarboxy fac torXwas immunochemica l l yquant i ta tedwi th the techn ique
of :Laurell 1221. Electrophoresis was performed 
(10 volts/cm for 3 h) tnLo a t7o
agarosege lcontarn i * ' , "an t i -bov jne fac torXant iserum,us ing0 '05Mbarb i ta l
b u f f e r p H 8 . 6 i n t h e p l e s e n c e o f 2 . } m M c a l c i u m - l a c t a t e . A s s t a n d a r d w a s u s e d
a plasma obtained from a cow under deep anticoagulation 
(factor X activity
l e s s t h a n S % \ . o n e u n i t i s a r b i t r a r i l y d e f i n e d a s t h e c o n c e n t r a t i o n o f f a c t o r
X-related antigen in 1.0 ml of standard plasma'
The crossed immunoelectrophoresis was carried out according 
to Laurell
[23] on glass plates (10 X 20 cm)' Agarose 
ge1 L]' \" 
0'05 M barbital buffer
p H 8 ' 6 c o n t a i n i n g 2 . 5 m M c a l c i u m . l a c t a t e o r E D T A i n t h e f i r s t d i m e n s i o n w a s
used. After the first dimension run, the agarose gel 0.5 cm 
above the slit was
rep lacedby: r%ug*o ' "conta in ingo '57"anL i -bov ine fac torXant iserumand
1,b mM 
"ut"ir_,*,I-u"tate. 
Electrophoresis in the second dimension was con-
tinued for 4 h, at 10 Vlcm. After the completion of the electrophoresis 
the gel
waswashedovern igh t insa l ine-phosphateso lu t ion , thenwashed ind is t i l l ed
water for 2 h, ari"E u"a stained wittr o.ozsTo coomassie 
Brilliant Blue R in
methanol/water/acetic acid (450 : 450 : 100, v/v)' Analyses 
were performed in
3 0 5
a LKB Multiphor 2717 apparatus. Double immunodiffusion was carried out
according to Ouchterlony [241.
Coagulation factor assay
Coagulation times specifically dependent on the concentrations of factor II,
vII, and X were obtained by mixing in a test tube at g?"c 0.1 ml bovine
plasma, artificially deficient in either factor II, vII, or X,0.1 ml sample and 0.1
ml bovine brain thromboplastin, prepared according to owren [25]. The
coagulation reaction was started by adding 0.1 ml cacl2 solution 1ss mnay.
Coagilation factor concentrations are expressed as,a percentage of the content
in a normal bovine plasma pool, obtained from 20 cows. The concentrations
were calculated from the coagulation times in specific tests as described by
Ifemker et al. [26]. It is defined that 1 ml bovine plasma with a blood coagula-
tion factor activity of 70v/o contains 1 Unit of each of the factors.
Preparation of normal bouine factor X
Bovine factor X was prepared with the method of Jackson [27] with slight
modifications. The two forms of factor X, designated factor Xl and factor X2
[28] were separated by chromatography on eAE-sephadex. Therefore, factor
X eluted from the DEAE-sephadex corumn was dialyzed against 0.05 M tri-
sodium citrate, pH 7.0, and applied to a column of eAE-sephadex equilibrated
with the same buffer. Factor X was eluted with a lineaf gradient of 0.10-
0.35 M trisodium citrate, pH 7.0. The factor X1- and factor Xr-containing frac-
tions were pooled separately and concentrated in a Diaflow ultrafiltration cell
equipped with a PM-10 membrane. The concentrate was adjusted to pH g.1
with 1.0 M Tris ' HCl, pH 8.6. Diisopropylfluorophosphate (1.o M in
2-propanol) was added to a final concentration of 1 mM and incubated for 60
min at 4'c. After dialysis against 0.028 M Tris . HCI buffer, pH 7.4, containing
0.12 M Nacl during 48 h at 4"c with four changes, the factor X, and X, prep-
arations were stored at -80'C.
Induction of decarboxyfactor X in the cow
Four cows, weighing about b00 kg each, were orally given 600 mg
Marcoumar the first day, followed by 200 mg daily for 4--6 days. Blood
samples were drawn from a jugular vein each day during the treatment and
collected into polyethylene tubes (50 ml) containing 0.g ml of 0.7 M trisodium
citrate solution. The effect of Marcoumar was monitored by the assay of factor
II, vII, and X activity and by crossed immunoelectrophoresis of plasma
samples. At a factor X activity of about roro of the normal activity, 5 I of
blood were collected from a jugular vein of each cow in 1-l polylthyt".r"
bottles containing 100 ml 0.1 M sodium oxalate, 10 mg heparin, 10 g
benzamidine hydrochloride and 5 mg crude soybean trypsin inhibitor. After-
wards, the animals were given 50 mg vitamin K each. plasma was obtained by
centrifugation in an MStr Mistral 6 I centrifuge at 2500 rev./min during 20
min at 4 'C.
Preparation of decarboxyfactor X
Bovine decarboxyfactor X was preptrred as follows:
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S t e p l : R e m o u a l o f n o r m a l f a c t o r X . M a r c o u m a r p l a s m a ( 2 1 I ) w a s s t i r r e d
wittr 30 g moist gel AI(oH): in 150 ml water during 10 min at room 
tempera-
t u r e ' T h e A l ( o H ) 3 * u , ' " - o u " d b y c e n t r i f u g a t i o n a t 2 0 0 0 X g f o r ] . 0 m i n a t
4" C.
S t e p 2 : A d ' s o r p t i o n o f d e c a r b o x y f a c t o r X o n b a r i u m s u l f a t e . T h e s u p e r .
natant (21 1-50 ml) was stirred with 400 g barium sulfate suspended in 
a mini-
mal amount of o.457o (w/v) NaCl in LmM Tris buffer pl l  7.5 for 
30 min at
4"C. BaSO4 was removed by centrifugation at 1500 Xg for 5 min and 
washed
three times with 1 I of the same buffer. Protein was eluted from the 
Basoa
with 1050 ml of 0.12 M trisodium citrate in 0.05 M Tris 
' HCI buffer, pH 5'8
containing 0.01 M benzamidine-HCl and 40 mg purified soybean trypsin 
inhibi-
tor per litie, by stirring al4" C for 30 min' This step was repeated once'
step 3: nE,4.n_seihadex adsorption and. elution The combined 
BaSO+
eluates (2100 ml) weie diluted with an identical volume of distil led 
water and
adjusted to pH ?.1 with 1.0 M NaOH. A slurry settled by 
gravity of DEAE-
sephadex (80 ml) equilibrated in 0.06 M trisodium citrate in 0.05 
M Tris ' HCl
buffer, pH ?.1, *u, udd"d to the eluate and stirring was continued for 
about 30
min at room temperature until ali factor X-related antigen was 
bound to the
D E A E - S e p h a d e x . l n a d d i t i o n , t h e D E A E - S e p h a d e x w a s w a s h e d w i t h l l o f
0 . 1 M N a C l i n 0 . 0 2 M p o t a s s i u ' n p h o s p h a t e b u f f e r o f p H 6 ' 8 ' T h e D E A E -
S e p h a d e x w a s p a c k e d l ' t o a c o l u m n ( 4 5 x 2 ' 5 c m ) o n t o a 3 c m h i g h D E A t r -
sephadex layer equilibrated in the final washing buffer. Decarboxyfactor 
X was
eluted using a linear gradient of 0.1-0.6 M NaCl in a 0.02 M 
potassium phos-
phate buffer of pH 
"6:8 
containing 1 mM benzamidine hydrochloride' Each
chamber contained 250 ml of the solution. The effluent of 
the DEAE-
sephadex column was monitored by rocket immunoelectrophoresis 
according
toLaure l l [22 lus ingamonospec i f i can t i -bov ine fac torXant iserum.
Step4:QAT-Sephadexchromatography .Thedecarboxy fac torXf rac t ions
from the DEAE-sLphadex column were pooled, dialyzed overnight 
against
0.0b M trisodium ciirate, 1 mM benzamidine hydrochloride 
pH 7'0' The same
QAE-Sephadex chromatography procedure as 
described for factor X purifica-
tion was followed. Oecariloxytacior X-containing fractions were 
identified by
rocket immunoelectroPhoresis'- " " 
it 
" 
p-i'' i 
" 
p ar:atiu e' p oly acry lam id e ge I e le c t r o p hor e sis' The decarboxy factor
X-containing fractions from the QAE-Sephadex column were dialyzed 
against
2 mM Tris ' HCI ' glycinate buffei, pH b'?, 10 mM in benzamidine 
hydro-
chloride, urro 
"orlJ*trated 
in a Diaflow ultrafiltration cell equipped with.a
pM-10 membrane (Amicon corp. model202). Generally 40 mg of 
protein in
3-4 ml dialysis nuiler containing 2O7o (vlv) sucrose were subjected 
to prepara-
tive polyacrylamide gll "lectroplioresis 
on a gel bed of 10 cm in the LKB 7900
Uniphor apparatus. iractions of a.O ml were collected. The elution 
buffer was
pumped at a flow rate of 30 ml/h. Electrophoretic conditions were 
700 v and
18 mA. Composition of the gel solution,' 'ol,'tio'. ' A, 30 g acrylamide 
and 0.9 g
bisacrylamide dissolved in 100 ml water; solution B, 0.08 
M Tris'glycine
b u f f e r , p H S . ? , a n d 4 m M b e n z a m i d i n e H C l ; s o l u t i o n C , ] . 4 0 m g a m m o n i u m
persulfate dissolveJ in 1OO ml water. Final gel solution was obtained by 
mixing
1- vol. A, 1 vol. B and 2vol. C. According tt ttre nomenclature of 
Hjerten l29l
T = 7 .bVo and C = BTo. ElecLrode chambeis contained 20 mM Tris 
' glycine and
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1mM benzamidine hydrochloride at pH 8.7. The elution buffer was the same
as the electrode buffer. The decarboxyfactor X containing fractions were
pooled and concentrated in a Diaflow ultrafiltration cell equipped with a
PM-10 membrane (Amicon Corp. Model2O2). The concentrate was adjusted to
pH 8.1 with 1.0 M Tris 'HCl pH 8.6. 1.0 M diisopropylfluorophosphate in
2-propanol was added to a final.concentration of 10-3 M. After dialysis against
0.025 M Tris ' HCl, pH 7.4 0.12 M Nacl during 48 h with four changes, the
decarboxyfactor X preparation was stored at -80'C.
Determination of NH2 terminal amino acids
Aminoterminal amino acids were determined qualitatively by the dansyl-
chloride procedure of Gray [30]. Dansylamino acids were identified o., poiy-
amide sheets using the procedure of Weiner et al. [81].
Amino acid analysis
The amino acid composition was determined according to spackman [82].
The proteins (0.5-1.5 mg) were hydrolyzed in 6 M HCI in evacuated pyrex
tubes at 110'c for 24 h. The analyses were performed on an LKB amino acid
analyzer 3201 using the one-column system of Hamilton [BB]. 7-carboxy-
glutamate was determined according to a modification of the method of
?vt\::i:Z [34]. Prior to hydrolysis, proteins (1.0 mg) were completely reduced
in [3H]diborane after 96 h of incubation at room temperature. The three iden-
tified [3H]diborane reduction products are: homoierine arising from the
aspartic acid, 5-hydroxynorvaline arising from glutamic acid, and
5,5'-dihydroxyleucine arising from 7-carbo"yglntu-ate. the specific activity of
5,5'-dihydroxyleucine is equal to half of theipecific activity o1homoserine and
5-hydroxynorvaline. The number of 7-carboxyglutamate residues was estimated
from the calculated specific activity of dihydroxyleucine (Kop, J.M.M. and
Hemker, H.C. (797 7), unpublished.)
Results
Preparation of monospecific antisera against bouine factors II, IX, and, x
Undiluted rabbit anti-bovine factor X, anti-bovine factor IX. and anti-bovine
factor II antiserum were allowed to diffuse against undiluted bovine plasma
(Fig. 1). single precipitation lines were formed, showing a monospecificity of
each of the antisera. A faint extra precipitation line is seen when normal bovine
plasma reacts with the antifactor X antiserum. We have not been able to distin-
guish between the two possible explanations viz. (a) An antibody against a
trace contaminant in the factor X preparation; (b) a derivative of factor X in
the normal plasma preparation. This experiment shows that factor II, factor IX,
and factor X have no antigenic determinants in common, because all reactions
show non-identity of both antigens and antibodies.
Preparation of decarboxyfactor X
A representative preparation of decarboxyfactor X is summarized in Table I.
Unlike decarboxyprothrombin and decarboxyfactor IX, decarboxyfactor X will
adsorb quantitatively onto 10 mg Al(oH)3/ml plasma. However, normal factor
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Fig . l .Doub. le immunod i f fus ionpat te rno f theant ibodyused.cent lewe l l ,normalbov inep lasna;we l ls l
and 4, anti-facto" tr atti""'i'-tii 
-"U" ' and 5' antifacto'-ix ottitu^t; 
wells 3 nd 6' anti-factor x anti-
sexum.
1 0 0
S  r r
.9
i z t
25 50 75 1oo
AL(OH): (mg/mt Ptasma)
50 7.5 l0.o
AL(OHb (mg/mt Ptasm:)
Fig,'2. Adsorption of factor 
II '  IX' and X and their-analog 
decarboxvfactors onto Al(oH)r 
from oxalat'ed
prasma. A Factor rr (.), factor vII (^), ."::l *,1::::;:^**,:il:"Jx1ltil,::tT::ff:1"t-::
!-,1T1,,1;i:ii"-#":]'it*, 
"."'.1-,'ii;';;;l{i-;''"; concentrations or Ar(oH)3' Adsorption was
performed at room ,"-o"r.iJ". *ring 
ro min. clottinE factor activitv 
was measured bv one stage assavs
as described under MethodJ.' i-. 
o""uJo*"p"otr'"o-tit"(t) '  o""u'uo*vtt"tor' 
IX (o)' decarboxvfactor 
x
(X) concentration in the supematant 
of normal bovin" otirt"" a""t inan 
bvo of Jhe normal f actor II' 
factor
lx. and factor X u""t"tt"l-^i i" iui"o"lt ioa 
-ittt Aitt-"]""i concentrations of 
Al(OH)r' Adsorption was
p e r f o r m e d a s d e s c r l b e d a b o v e . T h e c o n c e n t l a t i o n s o f d e c a r b o x y f a c t o l w e l e d e t e m i n e d b y r o c k e t'i--*to 
electrophoresis as described under 
Methods'
6 0 % .
L O %
20%
s
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T A B L E  I
PURIFICATION OF DECARBOXYFACTOR X FROM COUMARIN OXALATED PLAS\XA
Results of 
" "epr"."rtJiit" 
eipb?iment.startine with 21 I bovine plaffia.
ri
f  r a c E o n
I j
Volume
(ml)
C o n c e n . .
tration i
(unit/mI)
Protein
(mslml)
S p e c .  a c t i
(uni t  /mg)
Yield
(vo)
Purification
(-fold)
Plasma
BaS$+ eluate
DEAE-Sephadex
QAdsephadex
Final prbparation
21 000
2  100
237
220
rt2
1 . 0
r,3.3
10.3
A '
77 ,
5 .9
'1 ,
o .4
o .1
0 .o13
o.4
1  1 . 0
25.O
43 .0
100
2 5
1 5
1 0
2
L
850
1900
3300
X will adsorb quantitatively onto 2.b mg AI(oH)3/ml plasma (Fig.2). The
supernatant of marc6umar plasma treated with 2.b mg AI(oH)r7ml plasma
therefore contained most"bf the decarboxyfactor x, hardly itry id"tortX land
small ambunts of the factofs,i[I qnd IX. It fherefore is a suitable starline
material for the preparation of decarboxyfactor.X.
5 1 0 1 5 2 0 2 5 3 0
B a S O 4  ( m s / m t  p t a s m a )
Fig. 3. Adsorption of decarboxyprothrombin, decaboxyfactor IX, decarboxyfactor X and factor X from
oxalated bovine plasma onto BaS04. Decarboxyprothrombin (o), decarboxyfactor IX 1r;. and decarboxy-
factor X (r) conceniration in the supernatant of bovine coumarin plasma (less thm ,Vo of the clotting
factor lI, IX, md X activity) after ad.sorption during 30 min at room temperature with different concen-
trations of BaSO4. Factor X concentration (r) in the supernaiant of nomal bovine plasma after adsorp-
tion with BaSO4 under the sme conditions as described above. The concentrations were determined bv
rocket irnmunoelectrophoresis as descrit jed. under Methods.
G 6 0
s
o
* + u
o i
;
o
310
0.6 M NaCl
o.4
o.2
:€
-.J-.:-=2-,
120 130
lraction numbet
Fig.4. Step 3 in d.ecarboxyfactor x preparation. DEAE-Sephadex chromatographv of 
Basoa eluate in
potassium phosphate o.o2 M + NaCl O,1 M pH 6.8, Aftel washing the column wittr 4oo ml of buffer' a
gradient was applied ranging from 0.1 to 0.6 M NaCl in O.O2 M potassium phosphate buffer. 
pH 6'8' Each
gradient chamber contains 25O ml of the gradient solutions. Bed dimensions of the anion-exchanger.
45X2.5 cm. Flow rate of 4O ml/h and fraction volume bml' '- ' '  Absorbance 
at 28O nm;
H. decarboxyfactor X concentration; ---. gradient'
Unlike decarboxyprothrombin and decarboxyfactol IX, decarboxyfactol X
will adsorb quantitaiively onto 30 mg BaSO+/ml (Fig. 3). This is in variance
with the results of Gaudernack [35,36].
After dilution of the BaSO+ eluant (1 : 1 with distilled water and adjusted to
pH 7.1 with 1 M NaOH) decarboxyfactor X was quantitatively adsorbed_ont-o
DEAE-Sephadex equilibrated in o.oz M potassium phosphate buffer, 
pH 6.8,
"o"tui"itrg 
0.1 M NaCl. Fig. 4 shows the elution pattern of decarboxyfactor X
from DEAE-sephadex. Decarboxyfactor X was eluted as a single peak at 0.3 M
NaCl. The next step was QAE-sephadex chromatogtaphy of which Fig. 5 shows
the elution pattem. Like factor X, decarboxyfactor X is eluted in a double
peak at 0.18 M and. 0.22 M trisodium citrate. Only in fraction 180 a trace
amount of factor X activity (Iess than 5%) could be detected'
Polyacrylamide gel electrophoresis shows that the decarboxyfactol x prep-
aration contains several protein bands after the QA[-Sephadex step, in contrast
to the factor X preparatlon after QAE-Sephadex, which is almost pure (Fig. 6).
A further purification of decarboxyfactor X was obtained by preparative poly-
acrylamide gel electrophoresis. The elution profile is shown in Fig. 7. Decar-
boxyfactor i is eluted in the first major protein peak. Less than 1vo factor X
acdity could be detected in the pooled decarboxyfactor X fractions. Analyti
cal poiyacrylamide gel electrophoresis shows no inhomogeneity in this final
decarboxyfactor X pieparation. It has the same electrophoretic mobility as fac-
tor X (geis b and 6;f nig. 6, respectively). Like factor X, decarboxyfactor X is
highly susceptible to proteolytic enzymes. A proper yield of decarboxyfactor X
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Fig.5. Step 4 in decarboxyfactor X prepilation. QAE-sephadex chromatography of decarboxytactor
X-containing fractions obtained after DEAE-Sephadex chromatography. 24O ml of protein solution
(1.O mg/ml) in O.Ob M sodium citrate buffer. pH 7.O, was applied to QAE-Sephadex equil ibrated in the
same buffer. After washing the column with 60O ml of O.1 ml trisodium citrate buffer, pH 7.0. a gmdient
(2 X 3OO ml) was applied ranging from O.1 to 0.35 M trisodium citrate buffer, pH 7.O. Bed dimensions
of anion-exchanger, 3O X 2.5 cmi flow rate of 1O ml/h and fraction volume 5 ml. .-.,, Absprbance.
at 2 80 nm ; o-c, decilboxyfactor X concentration i -. gradient.
Fig. 6. Analytical polyacrylamide gel electrophoresis of normal bovine plasma and several fractions,
obtained during the purif ication procedures. 1, Nomal bovine plasma, TO pg:2, BaSO4-eluate from
decaboxyfactor X purif ication, 1OO l1gi 3, decilboxyfactor X after DEAE-Sephadex. 45 lrgi 4,
decaboxyfactor X after QAE-Sephadex, 50 pg;5, decarboxyfactor X after preparative polyacrylamide gel
electrophoresis, 5O pg:6, factor X after QAE-Sephadex, 3O pg.
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Fig. ?. Purif ication of decarboxvfactor X bv ,qr€parative 
polvacrvlamide gel electrophoresis' 3 ml
decuboxyfacto" x-".rtuirire fractions atter ei 'g-sephaddx 
(10 mglml) were applied on a gel ( 'r 
= 7
;;;: ;;;-i;;t;tt"- lensth. Fraction volume 3'o ml' 
}-' ' Absorbance at 2Bo nm;
I"l;r"o"""i."iotl" 1;""""r*tion; t.d., tracking dye. Detailed experimental 
conditiirns ae descritlr
:
under Methods: r:
l
cbuld oirly''be obtained by 4dding'benzamidine hydrochl?Iid",,l" l-t
.iAine in the last purification step results in the appear
of three different degladation products of deearboxyfactor 
X, as judged
Dolvacrylamide gel electrophoresis'
""Tn"^ii"J- p"titi"uti"n ( isoox) is relativelv :mall compar":$ 1", ll11 ",i
X. which can reach 1O fiOO Several explanations a.re possible: 
(a) M-uj9t
;hil;;il ui 
"".trt"t 
protein. This can be ruled o9t on. jhg f?tk 9l 
th:
that gO% of the pr"p*uiion can be activated,to obtain a titiatable 
active centr
as is shown in article B of this series (ref. 43). (b) Incomparability- 
of a uni
of factor X and a unit of decarboxyfactor x. (c) Incomparability 
between
unitofdecarboxyfactorXinful lplasmaandinthef inalpr]oduct '
At the moment we cannot offer a definite explanation' Both explanations
and c are based on the fact that electrophoretic mobility and 
immunologi
reactivity of factor X and decarboxyfactor X are not identical 
und'er varir
circumstances, which is very proLrablL. Also, the number of molecules 
presen
in the plasma of an anticoaguiated cow that was used as a standard 
need not b
the same as that of factor X in normal plasma'
Relatiue electrophoretic mobiltty of d'ecarboxyfactor X and factor 
X
il;;;;il;fi; t4l th; ellctrophoretic mobility of normal:T:"ilt]
a Ca2*-containing buffer than inagarose gel electrophoresis is lower in r -,----^--^+L-^*r-.i,
EDTA.containingbuffer,whereasthemobi l i tyofdecarb'oxyprothrombin
;;"ff."fi ny Cit.. Agarose gel electrophoresis of factor X and 
decarboxy
tor X in the Presenceof Ca'l or EDTA deru-onstrates identical 
differences
buff
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affinity to Ca2* for decarboxyfactor X and factor X. It is also shown that
decarboxyfactor X has a somewhat lower electrophoretic mobility than factor
X in the presence of EDTA, which indicates a lower net negative charge of
decarboxyfactor X.
Molecular size of factor X and decarboxyfactor X
Electrophoresis on polyacrylamide gel in the presence of sodium dodecyl
sulfate according to Weber [19] of both factor X and decarboxyfactor X
revealed a major single protein band with a moleqular weight around 55 000
(Fig. 8). After reduction of the S-S bonds with B-mercaptoethanol both pro-
teins show two protein bands with molecular weights of approximately 44 O00
and 17 000. The molecular weights of decarboxyfactor X and factor X esti-
mated by this method are in good agreement with the molecular weight
reported for factor X [27,281.
Immunochemical properties
A double irnmunodiffusion test of purified factor X, decarboxyfactor X,
normal bovine plasma and phenprocoumon plasma with less than |Vo factor X
activity against anti-bovine factor X antiserum shows one precipitation line. A
reaction of complete identity was seen between all samples and the antiserum
(Fig. e).
When purified factor X and purified decarboxyfactor X were analyzed by
crossed immunoelectrophoresis in calcium-containing buffer, single symmetri-
Fig. 8. Sodium dodecyl sulfate gel electrophoresis of factor X and decaboxyfactor X. Gel electrophoresis
system of Weber and Osborn [19]. 1, Factor X, disulfide reduced; 2, factor Xt 3. decarboxyfactor X.
d isu l f ide  reduced i  4 ,  decarboxy fac tor  X .  Approx imate  loads  fo r  each ge l .  15-2O gg o f  p ro te in ,
.:
J I A
F i g ' g . D o u b l e i m m u n o d i f f u s i o n . C e n t r e w e l l c o n t a i n e d a n t i . b o v i n e f a c t o l x a n t i s e r u m . w e l l l ' c
bov ine  p lasma;  2 ,  decarboxy fac tor  X ;3 ,  fac to r  X ;4 '  normal  
bov ine  p lasma '
TABLE I I
AMINO ACID COMPOSITION OF FACTOR X AND DECARBOXYFACTOR 
X
cal arcs were obtained with both prbtdins showing a higher electrophorr
mobility for-decarboxyfactor x. with this'technique factor x 9?"11:?,
J"t""t"i i" dlit decarbtxyfactor X prepiyation. In the presence bf EDTA t
pt""ipitution arc of decarboxyfactor X is at the sbme position as that fou
for factor X. The immunoelectrophoretic pattelns obtaing{ with the 'purifi
;;;#;;"t; ,,:odtaiir".""t froiri t{gse, obtaipeg with 
upfractionated p}asma'
Amino acid Factor X
(mol /50  00O)  *
20
1 1
2 5
40
2 8  * +
3 1  * *
b I
20
4 2
J A
1 9
20
6
1 1
J J
1 1
22
L 2
1 3
Decarboxyfactor X
(mot /5o  000)  *
27
1 1
2 5
L t
28
30
6 1
1 8
29
20
22
o
1 3
29
1 1
22
< 1
< 1
Factor X (refs. 37'
(mo l /5o  0OO)  *
2L
1 0
2 5 *
40
3 0 ' {
29
6 1
20
4 l
3 1
24
24
6
1 1
32
9
2 l
s f
1 3 f
Lysine
Histidine
Arginine
Aspadic acid
Threonine
Serine
Glutamic acid
Proline
Glycine
Alanine
HaIf-cystine
Valine
Methionine
Isoleucine
Leucile
Tytosine
Phenylalmine
"y-Carboxyglutamic
ac id  +x*  I
7-Carboxyglutamic
ac id  * * *  2
*  Mo lecu la  we igh ts  do  no t  inc lude the  cabohydra te  conten t  [37 ] '
* x Values d.etcrmined by extrapolation to zero-time hvdrolysis'
.-* .,,r]u"" 
"oi"-"o 
urt"" ,"or"tior with [3H]diborane and acid hydrolvsis as 
described under
' 
oils. 1 antl 2 refbr to factpi Xl and facto{ X2, respectivelv'
f  vu l r " i  t . k " r  f iom Nea l  e t  a l .  [411.
. r G - ,
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Amino acid analysis
The amino acid composition of decarboxyfactor X and factor Xt,2 appeared
to be identical within the experimental error (Table II), and is in good agree-
ment with published data f28,37l. The composition given is the average of two
different preparations of each of the proteins. The number of 7-carboxy-
glutamate residues was determined in decarboxyfactor X, factor X1 and factor
X, by a modification of the method of ZyLkovicz [34] as described in
Methods. Less than one 7-carboxyglutamate residue was detectable per mol of
decarboxyfactor X. No differences were found in the 7-carboxyglutamate con-
tent of factor X1 and factor X2 (Table II). These results are in close agreement
with the number of 7-carboxyglutamate residues suggested from analysis of the
N-terminal portion of the light chain, prepared from a mixture of factor X1 and
factor X, [38].
Aminoterminal amino acid analysis
Qualitative aminoterminal amino acid determination of decarboxyfactor X
and factor X with a method according to Gray [30] showed a single intensive
spot and several very weak spots by chromatography on polyamide sheets as
described by Weiner et al. [31].In both factor X and decarboxyfactor X the
main spot was identified as dansylalanine. Fujikawa [28] reported the sequence
of the NH2-terminal region of the heavy chain to contain Trp-Ala-Ile-His. With
the method of Gray [30] tryptophan deglades and, therefore, cannot be
detected.
Discussion
A protein induced by vitamin K antagonists, analogous to prothrombin,
(decarboxyprothrombin) has been demonstrated and isolated by many investi-
gators I1-4] . In earlier publications we demonstrated the existence of an
abnormal factor X in plasma of phenprocoumon-treated cattle (defined as
decarboxyfactor X) which is ineffective in blood coagulation [14,15]. Recent
advances in chemical analysis of the difference between prothrombin and
decarboxyprothrombin suggest that the vitamin-dependent mechanism serves
to modify glutamate residues into 7-carboxyglutamate residues [6,8]. This may
cause the differences between prothrombin and decarboxyprothrombin in
biological activity, calcium binding and adsorption to insoluble inorganic salts.
In addition our results on decarboxyfactor X may represent a situation parallel
to that found for decarboxyprothrombin.
The results we obtained when studying the adsorption of decarboxyfactor X
onto AI(OH)3 and BaSOa not only provided a useful first step for the purifica-
tion of decarboxyfactor X but also raise a question of theoretical interest. It is
generally accepted that the quantitative and selective adsorption of prothrom-
bin onto BaSO+ is a function of the 7-carboxyglutamate residues. It appears
that other influences play a role as well, as decarboxyfactor X that does not
contain 7-carboxyglutamate residues adsorbs at a slightly higher BaSOa concen-
tration than does normal factor X. This result pertains to the interpretation of
earlier results of Hemker et al. [13]. They described a protein that competi-
tively inhibits tests of the prothrombin-time (c.q. Quick-time) type. From this
a-
:
t .  .  .
. i I f )
they concluded that in dicoumarol treatment abnormal prothrombin'li
molecules, probably precursors of the:normal factors, circulate. Later
localized the site of inhibition of the blood coagulation seciuence at bonversi
of factor X and inferred that the inhibition is a factor X analog, i.e., decarbox
factor X [401.
Therefore, in the light of the findings presented in this paper this claim
not be''challenged on the bases that the inhibitor was reported to be adso
onto AI(OH)3 and BaSO+.
Comparison of the electrophoretic mobility of prothrombin and factor
may reveal a larger net negative change on factor X. The more anodical posit
of decarboxyfactor X relative to that of decarboxyprothrornbin also indi
the same difference in net negative charge [14]. These facts may explain
higher affinity of decarboxyfactor X towards insoluble barium salts as
pared with decarboxyprothrombin. The isolation procedure of decarbo
factor X described in this paper yields a preparation which is fairly pure
judged by several criteria; e.g.'gel electroph'oresis and aminoterminal ami
acid analysis. The hetefogen'eity of decarboxyfactor X, as demonstrated in
QAE-sephadex elution profile, is of interest. It is unlikely that this phen
non is due to the pres€nce of factor X, bbcause the factor X activity is far
than would be expected from the amount of precipitable antigen.
It was reported by Neal et al. [41] that factors X1'and X2 differ in
7-carboxyglutamate content (8 and 13 residues, respectivdly) and that
differences may be accounted for by the different behaviour on anion-excha
chromatography. However, in our hands an equal amount of 7-carbox
glutamate residues was found in both factor X1 and factor X2. Mo
decarboxyfactor X, which contains less than one residue of 7-carbo
glutamaie, also shows heterogeneity on anion-exchange chromatography und
certain conditions.
Decarboxyfactor X iis'very similar to factor X on the basis of mol
weight, polypeptide chain composition, amino acid composition, ami
terminal amino acid. immunochemical reaction and its behaviour on pol
acrylamide gel electrophoresis. Furthermore, it is shown that the purifi
decarboxyfactor X and the native protein in unfractionated plasma are simi
as they have identical immunochemical and electrophoretic properties.
Based on amino acid analvsis the difference between factor X and d
boxyfactor X in biological activity and Ca2* binding may be explained by th
difference found in 7-carboxyglutamate content. Ca2* binding properties o
decarboxyfactor X and their role in the conversion of the zymogen in a serin
protease, analogous to factor Xa, are reported in the following papers [42,431.
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